EUVIMEDEUVIMED entdecken
Crossref

A Novel Peptide Aldehyde with Activity against Human Cytomegalovirus in Two Different in Vivo Models

O Weber, J Reefschläger, H Rübsamen-Waigmann, S Raddatz, M Hesseling, D Häbich

Antiviral Chemistry and Chemotherapy · 2000

DOI: 10.1177/095632020001100105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antiviral Chemistry and Chemotherapy, 2000. Verfasst von O Weber und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antiinfective Research, Virology, Bayer Pharmaceutical Research Centre, Wuppertal, Germany. Olaf.Weber.OW@bayer-ag.de. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel peptide aldehydes (PAs) were identified as potent inhibitors of human cytomegalovirus (HCMV) in vitro. Although these compounds were highly effective against HCMV, they did not exhibit any activity against murine cytomegalovirus (MCMV). The purpose of this study was to test the antiviral activity of PA 8 as a representative of this novel class of inhibitors against HCMV in vivo. Because of the strict species specificity of HCMV we had to use two artificial animal models. In the first model, HCMV-infected human cells were entrapped into agarose plugs and transplanted into mice. In the second model, SCID mice were transplanted with human tissues that were subsequently infected with a clinical isolate of HCMV. In these two models the antiviral activity of PA 8 was clearly demonstrated, ganciclovir only being slightly superior in its in vivo antiviral activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AldehydesAnimalsCytomegalovirusFemaleHumansMagnetic Resonance SpectroscopyMiceMice, SCIDMicrobial Sensitivity TestsPeptidesSpectrometry, Mass, Fast Atom Bombardment

Substanzen

AldehydesPeptides

Autor:innen und Institutionen

  • Department of Antiinfective Research, Virology, Bayer Pharmaceutical Research Centre, Wuppertal, Germany. Olaf.Weber.OW@bayer-ag.de

Zitieren

APA

Weber, O., Reefschläger, J., Rübsamen-Waigmann, H., Raddatz, S., Hesseling, M., & Häbich, D. (2000). A Novel Peptide Aldehyde with Activity against Human Cytomegalovirus in Two Different in Vivo Models. Antiviral Chemistry and Chemotherapy. https://doi.org/10.1177/095632020001100105

Vancouver

Weber O, Reefschläger J, Rübsamen-Waigmann H, Raddatz S, Hesseling M, Häbich D. A Novel Peptide Aldehyde with Activity against Human Cytomegalovirus in Two Different in Vivo Models. Antiviral Chemistry and Chemotherapy. 2000. doi:10.1177/095632020001100105

BibTeX
@article{Weber2000,
  author = {Weber, O and Reefschläger, J and Rübsamen-Waigmann, H and Raddatz, S and Hesseling, M and Häbich, D},
  title = {A Novel Peptide Aldehyde with Activity against Human Cytomegalovirus in Two Different in Vivo Models},
  journal = {Antiviral Chemistry and Chemotherapy},
  year = {2000},
  doi = {10.1177/095632020001100105}
}
Kostenlos starten →